Mainstream Brands Engage CBD Consumer Segment as 66% of Americans Consider Cannabinoid Products

WASHINGTON–(Business Wire)–New Frontier Data, the global authority in data, analytics and business intelligence for the cannabis industry, releases Cannabis-Infused Products: Navigating the Complexities to Market, Vol. 2, in partnership with SōRSE Technology. The report explores the fundamental areas of cannabinoid-infused product development, the unique regulatory hurdles constricting the market, and the effective strategies that brands use to capture market share.

“New Frontier Data’s research shows cannabis and CBD consumers vary widely in their demographics, product preferences, purchase behavior, reasons for use and consumption frequency,” said New Frontier Data Founder & CEO Giadha A. DeCarcer. “In such a dynamic consumer environment, brands must develop data-driven consumer strategies to secure their market position as competition intensifies and the product landscape becomes more saturated.”

Other key findings from the report include:

  • 66% of Americans surveyed have had positive conversations about CBD, revealing a dynamic and positive perspective towards CBD
  • 18% of Americans surveyed have consumed CBD products, with widely varied reasons for use including pain, medical, unwinding and general wellness
  • THC-infused edibles are legal in states where medical or adult use cannabis is legal, but the licensing requirements to be a cannabis-infused product manufacturer vary widely
  • The national rules governing CBD are still in flux, with a decision still pending from the FDA on whether CBD-infused food will be permitted in the general commercial market

The Cannabis-Infused Products: Navigating the Complexities to Market, Vol. 2 is available free of charge: Download at: www.NewFrontierData.com/cannabisinfusedvol2

About New Frontier Data:

New Frontier Data is an independent, technology-driven analytics company specializing in the global cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policy makers. New Frontier Data’s reports and data have been cited in over 80 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C., with additional offices in Denver, CO and London, UK.

New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data, please visit: https://www.NewFrontierData.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200917005131/en/

Caroline Kowalski
media@NewFrontierData.com

Original Article: http://www.digitaljournal.com/pr/4809858

The post Mainstream Brands Engage CBD Consumer Segment as 66% of Americans Consider Cannabinoid Products appeared first on CBD Health and Wellness.

Continue Reading Mainstream Brands Engage CBD Consumer Segment as 66% of Americans Consider Cannabinoid Products

More Americans Consider CBD, Giving Insurance and Other Ancillary Businesses a Push

Most people in the cannabis space expect CBD to be big, but a new report highlights the potential of the cannabis product, which has some in the insurance community already stepping up their game.

New Frontier Data on Thursday issued its latest report, Cannabis-Infused Products: Navigating the Complexities to Market, Vol. 2, in partnership with SōRSE Technology.

Among its findings is that nearly one-in-five Americans polled said they have consumed a CBD product.

The report from the Washington, D.C.-based data analytics company specializing in the global cannabis industry explores areas of cannabinoid-infused product development, regulatory hurdles constricting the market and strategies that brands use to capture market share.

“New Frontier Data’s research shows cannabis and CBD consumers vary widely in their demographics, product preferences, purchase behavior, reasons for use and consumption frequency,” said New Frontier Data Founder & CEO Giadha A. DeCarcer. “In such a dynamic consumer environment, brands must develop data-driven consumer strategies to secure their market position as competition intensifies and the product landscape becomes more saturated.”

Norman Ives, a broker and cannabis practice leader at wholesaler Worldwide Facilities LLC, said the wholesaler’s Nutrarisk division has lately kicked it into high gear to capture anticipated CBD-related business.

“We saw a huge growth spurt last year,” said Ives, who has been broking in the cannabis space for the past eight years. “We probably wrote more hemp/CBD policies last year than we did marijuana policies.”

Worldwide recently launched an exclusive program focused on CBD and nutraceutical products in London under its Nutrarisk program that’s placed with Lloyd’s.

The majority of cannabis-related business the firm wrote last year were farming-specific risks. This year the big push in new business for Nutrarisk has been in extraction of hemp, and making it into isolates and distillates, according to Ives.

“This year it’s far more processors,” Ives said. “By and large the largest growth I’ve seen has been in drying, processing and extracting hemp.”

There’s also a downside to insuring CBD, with nearly a dozen major CBD-related class action lawsuits, as well as a handful of legal and regulatory actions against some CBD companies.

Key findings from the New Frontier report include:

  • 66% of Americans surveyed have had positive conversations about CBD, revealing a dynamic and positive perspective towards CBD
  • 18% of Americans surveyed have consumed CBD products, with widely varied reasons for use including pain, medical, unwinding and general wellness
  • THC-infused edibles are legal in states where medical or adult use cannabis is legal, but the licensing requirements to be a cannabis-infused product manufacturer vary widely

The report also notes that national rules governing CBD are still in flux, with a decision still pending from the FDA on whether CBD-infused food will be permitted in the general commercial market

The free report can be downloaded directly from New Frontier’s website.

Original Article: https://www.insurancejournal.com/news/west/2020/09/17/583037.htm

The post More Americans Consider CBD, Giving Insurance and Other Ancillary Businesses a Push appeared first on CBD Health and Wellness.

Continue Reading More Americans Consider CBD, Giving Insurance and Other Ancillary Businesses a Push

FDA: We Still Don’t Know Enough About CBD

US Food and Drug Administration (FDA) commissioner Stephen Hahn told a Congressional subcommittee that more research and data are needed before the FDA is ready to issue a formal policy on cannabidiol (CBD) products. Meanwhile, the FDA has created an online portal to collect scientific data and studies from the public regarding the safety and efficacy of CBD.

“We have a knowledge gap…that makes it difficult for us to know how to proceed in several areas,” Hahn said. “The critical need here–besides getting the enforcement policy forward and providing regulatory clarity–is conducting the research and gathering the data.”[1]

One area in particular that Hahn said needs more research before a rule can be firmly established is whether an upper limit to the amount of CBD that a product contains should be set.

“It would be very difficult and [there is] not a lot of science and data behind being able to establish that upper limit at this point,” Hahn told the subcommittee. “I don’t see that happening right now until we gather additional information.”[1]

Hahn was fielding questions about the FDA’s ongoing efforts to regulate CBD products during testimony before a House Committee on Appropriations subcommittee, after the agency submitted a report providing an update. The FDA acknowledged in that report, “We have made progress but there are still areas where timely attention is needed.”[2]

Two other central themes emerged in the subcommittee hearing.

First was that the FDA has and will continue to enforce existing laws against companies making unsubstantiated health claims on CBD products.

In November 2019, the agency issued warnings to 15 companies accused of marketing CBD products with misleading labeling.[3] “We have taken action against companies who have made false claims about CBD products curing cancer, treating Alzheimer’s, and those are the highest risk areas. We will continue to enforce that,” Hahn said during his testimony to the subcommittee.[1,4]

Second, the FDA is exploring allowing CBD as a dietary supplement.

According to Hahn’s report to Congress, “Under current law, CBD products cannot lawfully be sold as dietary supplements, but FDA has the authority to remove this exclusion through rulemaking. We recognize the high level of interest in dietary supplements as a potential pathway for products containing CBD, and we are actively evaluating potential rulemaking to allow CBD in dietary supplements.”[1,2]

The FDA was slightly late in updating the subcommittee, which it was supposed to have done within 60 days of the passage of an appropriations bill in December providing $2 million for data collection and enforcement measures. When it came, at least one subcommittee member felt the update was inadequate.

“Many of us were disappointed that the report didn’t provide more clarity and concrete steps forward,” said Maine Democrat Chellie Pingree. “You haven’t taken any robust action to issue regulatory guidance that would clear the market.”

Up to now, the FDA has been slow in delivering tangible progress in instituting regulations on CBD products.

The agency’s approach appears to be to take action against clearly unsupported health claims and turn a blind eye to other products until it can produce a formal policy.

One might reasonably believe the FDA’s efforts to release comprehensive CBD regulations will be slowed further as it rightly focuses much of its efforts and resources towards fighting the COVID-19 pandemic.

Image Credit: Erin Hinterland

Image Source: https://pixabay.com/photos/cbd-oil-cannabidiol-cannabinoid-5358407/

Original Article: https://www.cbd-intel.com/fda-needs-more-data-before-making-cbd-rules-hahn-tells-us-hearing/

References

  1. Marijuana Moment. “FDA Chief Faces CBD Questions at Congressional Hearing.” Available at: https://www.marijuanamoment.net/fda-chief-faces-cbd-questions-at-congressional-hearing/ Accessed June 29, 2020.
  2. Council for Responsible Nutrition. “Report to the US House Committee on Appropriations and the US Senate Committee on Appropriations: Cannabidiol (CBD).” Available at: https://crnusa.org/sites/default/files/RAC%20attachments/CBD/CBD%20RTC%20Final.pdf Accessed June 29, 2020.
  3. US FDA. “FDA Warns 15 Companies for Illegally Selling Various Products Containing Cannabidiol as Agency Details Safety Concerns.” Available at: https://www.fda.gov/news-events/press-announcements/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details Accessed June 29, 2020.
  4. US FDA. “FDA Warns Company Marketing Unapproved Cannabidiol Products with Unsubstantiated Claims to Treat Cancer, Alzheimer’s Disease, Opioid Withdrawal, Pain and Pet Anxiety.” Available at: https://www.fda.gov/news-events/press-announcements/fda-warns-company-marketing-unapproved-cannabidiol-products-unsubstantiated-claims-treat-cancer Accessed June 29, 2020.

CBD-Intel provides impartial, independent, and premium market and regulatory analysis, legal tracking, and quantitative data for the CBD sector.

 We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimize resources and make informed decisions. In addition, we offer customized research and consultancy support.

The post FDA: We Still Don’t Know Enough About CBD appeared first on CBD Health and Wellness.

Continue Reading FDA: We Still Don’t Know Enough About CBD

How To Battle Animal & Mold Infestations in Outdoor Cannabis Grows

All outdoor marijuana crops have the potential to be destroyed by one or two of the various problems lurking in the wilderness, unlike indoor growing where plants are protected. In checking on the crop, make sure to keep an eye on the little details that will spell trouble later. There are a few different things to look for:

Aphids

An aphid infestation is a hard infestation to get rid of. For most of us, using chemical insecticide is the no-brainer solution, and they’re right. Aphids are very hard to kill. Chemicals can be used if the plant is still in the green foliage growth stage. If the scheduled harvest is just 2 or 3 weeks away, don’t use chemical insecticides, as the chemicals will still be present in the finished product. No one wants to risk the dangerous side effects of smoking chemicals.

The natural way to get rid of an aphid infestation on a marijuana plant involves a few steps and a bit of work. Go out and buy a few geraniums. Geraniums exude hormones that pests don’t like. Make a few palm sized cloth bags full of the geranium leaves and hang them on each plant. The hormones the geraniums exude will keep the aphids away. Now the aphid eggs left behind have to be dealt with.

Find a good thick soft cloth and some antibacterial / insecticide soap. The aphid’s eggs will be found mostly on the underside of the leaves of the plant. Using some care, just run the soapy cloth under each leaf, just once. You don’t want to scrub the leaves; just one pass over them will do if the cloth is good and soapy. You’ll feel a slight tug on the washcloth with every aphid egg that you’re displacing.

Depending on the degree of infestation, if you’re using a growing medium such as a peat and perlite mixture, the top coat might have to be replaced. The peat and perlite growing medium gives the aphids many crooks and crevasses to lay eggs in. Dig out the first inch or two and replace it with pH balanced peat and perlite mixture. Be sure to be careful around the roots and everything will be okay.

Since antibacterial / insecticide soap was used, be sure to mist the underside of the leaves for about a week to remove any traces of the chemicals in question. If there are buds present, try not to spray the pH balanced water on them. A happy nug is a dry nug.

Molds & Fungus

Since every grow operation requires standing water of some kind, one must at all times be vigilant when it comes to mold and fungal infestations. They both like to grow in standing water or on surfaces that are wet most of the time. Both molds and fungus can be made of some very nasty substances that can harm humans. If you suspect an infestation of mold or fungus, wear rubber gloves while checking things out.

The first sign of mold or fungus is the smell. It’s hard to not take a good sniff of each plant, as most stoners enjoy the scent of a marijuana plant. If you smell a damp and rotted scent while sniffing, you’ve got a problem. It might be time to break out the chemicals.

The first place to look for mold is on the part of the main stem that sticks out from the roots. Check to see if there is a slimy residue on it. If there is, then it’s time for the chemicals to come out. There is just no way around spraying the stalk with fungicide if it is moldy. This is because the base of the stem is where the plant supports itself and is the first part of the plant that allows the nutrients from the root to spread within the rest of the plant.

There might be the urge to wipe the now dead mold off of the stem. Try not to, because the mold might have punctured the stem all the way to the hollow core of the plant. Wiping away the dead mold will also wipe away the stem if it is dead. This will cause a stop in growth and possibly the loss of the plant as a whole. Leaving the stalk and the dead mold intact will keep the stem sealed – exposing the hollow inner core is a death sentence for the plant.

Marijuana is a very hearty and strong plant. It can live through some pretty major damage. While a mold and fungus infection may kill other plants, if the procedures outlined here are adhered to, the plant will live to maturity. It may have smaller buds than those plants without an infection, but it will still be greedily harvested once the buds have matured.

Mammals & Rodents

Animals love to nibble on marijuana. Whether it’s just the smell or taste or if they know that they can get high is unknown. The culprit most of the time is deer, as the first sign of having a foraging visitor nipping your buds will show on the top of the plant.

The only way to stop this foraging is to push a light mesh cover over your plants or to hang geranium bags on your plants. Animals hate the scent of geraniums, so they stay away from your plants. Another scent-based solution is mothballs. Most animals will shy away from mothballs, as the scent isn’t comparable to anything they eat in the wild.

In growing in the wild, there are bound to be a few deaths in the crop. Whether this is due to male culling or animals or mold or fungus, plant a few extra plants to make up for the future losses and the crop will turn out fine.

How do you combat pests? Tell us your grow tips below.

The post How To Battle Animal & Mold Infestations in Outdoor Cannabis Grows appeared first on Cannabis Now.

Continue Reading How To Battle Animal & Mold Infestations in Outdoor Cannabis Grows